Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$393,413
+$31,024 QoQ
Shares Held
328
-16.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
#3,950
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PALLADIEM, LLC holds $985,691 across 8 Drug Manufacturers - General names. LLY ranks #1 (39.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
328 | $393,413 | |
| 2 | NVS |
Novartis AG
|
1,996 | $312,813 | |
| 3 | AZN |
Astrazeneca PLC
|
1,416 | $268,501 | |
| 4 | JNJ |
Johnson & Johnson
|
19 | $4,825 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
19 | $2,400 | |
| 6 | AMGN |
Amgen Inc
|
4 | $1,448 | |
| 7 | MRK |
Merck & Co., Inc.
|
10 | $1,285 | |
| 8 | ABBV |
AbbVie Inc.
|
4 | $1,006 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $393,413 | 328 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $362,389 | 394 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $390,108 | 363 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||